<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Sripathy SP</submitter><funding>NCI NIH HHS</funding><pagination>6376-84</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4094353</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>27(49)</volume><pubmed_abstract>In the presence of ERbeta, trans-hydroxytamoxifen (TOT) protects cells against 17beta-estradiol (E(2))-induced oxidative DNA damage (ODD) and this correlates with increased expression of the antioxidative enzyme quinone reductase (QR). Here, we investigate the molecular mechanism responsible for ERbeta-mediated protection against ODD. We observe constitutive interaction between ERbeta and the novel protein hPMC2. Using a combination of breast epithelial cell lines that are either positive or negative for ERalpha, we demonstrate TOT-dependent recruitment of both ERbeta and hPMC2 to the EpRE (electrophile response element)-regulated antioxidative enzyme QR. We further demonstrate TOT-dependent corecruitment of the coactivators Nrf2, PARP-1 (poly (ADP-ribose) polymerase 1) and topoisomerase I</pubmed_abstract><journal>Oncogene</journal><pubmed_title>hPMC2 is required for recruiting an ERbeta coactivator complex to mediate transcriptional upregulation of NQO1 and protection against oxidative DNA damage by tamoxifen.</pubmed_title><pmcid>PMC4094353</pmcid><funding_grant_id>R03 CA130066</funding_grant_id><funding_grant_id>CA130066</funding_grant_id><funding_grant_id>CA92440</funding_grant_id><funding_grant_id>R01 CA092440</funding_grant_id><pubmed_authors>Gaikwad NW</pubmed_authors><pubmed_authors>Chaplin LJ</pubmed_authors><pubmed_authors>Montano MM</pubmed_authors><pubmed_authors>Rogan EG</pubmed_authors><pubmed_authors>Sripathy SP</pubmed_authors></additional><is_claimable>false</is_claimable><name>hPMC2 is required for recruiting an ERbeta coactivator complex to mediate transcriptional upregulation of NQO1 and protection against oxidative DNA damage by tamoxifen.</name><description>In the presence of ERbeta, trans-hydroxytamoxifen (TOT) protects cells against 17beta-estradiol (E(2))-induced oxidative DNA damage (ODD) and this correlates with increased expression of the antioxidative enzyme quinone reductase (QR). Here, we investigate the molecular mechanism responsible for ERbeta-mediated protection against ODD. We observe constitutive interaction between ERbeta and the novel protein hPMC2. Using a combination of breast epithelial cell lines that are either positive or negative for ERalpha, we demonstrate TOT-dependent recruitment of both ERbeta and hPMC2 to the EpRE (electrophile response element)-regulated antioxidative enzyme QR. We further demonstrate TOT-dependent corecruitment of the coactivators Nrf2, PARP-1 (poly (ADP-ribose) polymerase 1) and topoisomerase I</description><dates><release>2008-01-01T00:00:00Z</release><publication>2008 Oct</publication><modification>2025-04-26T09:14:43.034Z</modification><creation>2019-03-27T01:31:55Z</creation></dates><accession>S-EPMC4094353</accession><cross_references><pubmed>18663360</pubmed><doi>10.1038/onc.2008.235</doi></cross_references></HashMap>